| General Information | |||
|---|---|---|---|
| Term | Castleman disease | ID (Ontology) | DOID:0111157 (Human Disease) |
| Definition | A lymphoproliferative syndrome characterized by one or more enlarged lymph nodes containing cells with hyaline-vascular, plasmacytic, or mixed appearance microscopically. | ||
| Also Known As | "angiofollicular lymph hyperplasia" ; "angiofollicular lymph node hyperplasia" ; "giant lymph node hyperplasia" (for all, see Synonyms field below) | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
No relevant statements available
|
|||
|
||||||
primary immunodeficiency disease |__lymphoproliferative syndrome |__Castleman disease |__multicentric Castleman disease |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a | lymphoproliferative syndrome | ||
| Part of | |||
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
External Crossreferences & Linkouts
|
|||
|
GARD:12656 ICD10CM:D47.Z2 MESH:C536362 MESH:D005871 NCI:C3056 ORDO:160 SNOMEDCT_US_2023_03_01:207036003 UMLS_CUI:C0017531 UMLS_CUI:C2931179 |
|||